Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review10058-F4 is a cell permeable c-Myc-Max dimerization inhibitor. Inhibits proliferation, induces apoptosis and arrests cells in G0/G1 in rat1a-c-Myc cells. Also reduces tumor growth in vivo. In lymphoma cells, 10058-F4 decreases glucose uptake and expression of glycolysis-associated genes and reduces cell viability.
10058-F4 is also offered as part of the Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.
M. Wt | 249.35 |
Formula | C12H11NOS2 |
Storage | Store at +4°C |
Purity | ≥99% (HPLC) |
CAS Number | 403811-55-2 |
PubChem ID | 1271002 |
InChI Key | SVXDHPADAXBMFB-JXMROGBWSA-N |
Smiles | O=C(NC(S2)=S)/C2=C\C1=CC=C(CC)C=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 24.93 | 100 | |
ethanol | 4.99 | 20 |
The following data is based on the product molecular weight 249.35. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 4.01 mL | 20.05 mL | 40.1 mL |
5 mM | 0.8 mL | 4.01 mL | 8.02 mL |
10 mM | 0.4 mL | 2.01 mL | 4.01 mL |
50 mM | 0.08 mL | 0.4 mL | 0.8 mL |
References are publications that support the biological activity of the product.
Yin et al (2003) Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22 6151 PMID: 13679853
Huang et al (2006) A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp.Hematol. 34 1480 PMID: 17046567
Guo et al (2009) Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer Chemother.Pharmacol. 63 615 PMID: 18509642
Broecker-Preuss et al (2017) Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability J.Transl.Med. 15 158 PMID: 28724379
If you know of a relevant reference for 10058-F4, please let us know.
Keywords: 10058-F4, 10058-F4 supplier, cell, permeable, c-Myc, cMyc, inhibits, inhibitors, arrests, cycle, G1/G0, 10058-F4, antitumorigenic, antitumourigenic, proliferation, apoptosis, reduces, tumor, growth, tumour, c-Myc-Max, max, Cell, Cycle, Inhibitors, Myc, MYC, 4406, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for 10058-F4. Do you know of a great paper that uses 10058-F4 from Tocris? Please let us know.
Average Rating: 5 (Based on 1 Review.)
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
Used the compound for studying the anti-cancer properties. The compound 10058-F4, strongly induced caspase‐3‐dependent apoptosis in pre‐B ALL cells.
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.